Is Ashwagandha for Thyroid Worth Taking? A Look at the Clinical Trials

What the Clinical Trials Actually Say About Ashwagandha and Thyroid Hormones

Ashwagandha (Withania somnifera) has been used in Ayurvedic medicine for centuries, but its application to thyroid health has only been scrutinized in controlled trials relatively recently. The most cited study specifically examining thyroid outcomes is a randomized, double-blind, placebo-controlled trial by Sharma et al. (2018), published in the Journal of Alternative and Complementary Medicine. In that 8-week trial, 50 adults with subclinical hypothyroidism received either 600 mg/day of ashwagandha root extract or placebo. The ashwagandha group showed statistically significant increases in serum triiodothyronine (T3) and thyroxine (T4), along with a reduction in thyroid-stimulating hormone (TSH) — the key marker used to gauge how hard the pituitary is working to stimulate an underactive thyroid (Sharma et al., Journal of Alternative and Complementary Medicine 2018; PMID: 29727607).

These are not trivial findings. TSH reduction alongside T3/T4 elevation suggests the thyroid gland itself became more hormonally active, not just that a downstream marker shifted. That said, the trial enrolled adults with subclinical — not overt — hypothyroidism, meaning participants already had a functioning thyroid that was underperforming rather than failing entirely. Generalizing these results to autoimmune thyroid disease (Hashimoto's thyroiditis) or post-surgical hypothyroidism requires caution.

The biological mechanism most researchers point to involves ashwagandha's withanolide content. Withanolides are steroidal lactones that appear to interact with thyroid hormone synthesis pathways, possibly by stimulating thyroid peroxidase activity and modulating hypothalamic-pituitary-thyroid (HPT) axis signaling. Animal studies have demonstrated elevated T3 and T4 in rodent models following ashwagandha supplementation (Panda & Kar, Journal of Pharmacy and Pharmacology 1998; PMID: 9625537), providing a biological basis that the Sharma human trial later substantiated.

For a deeper look at the full clinical evidence for this adaptogen, including anxiety and muscle recovery data, the clinical evidence for ashwagandha benefits and dosage guide covers the broader research landscape.

---

Ashwagandha for Cortisol: Why Stress Hormones Matter for Thyroid Function

You cannot talk about ashwagandha and thyroid health without addressing cortisol. Chronic elevation of cortisol — the primary glucocorticoid released during the stress response — is one of the most underappreciated drivers of thyroid dysfunction. High cortisol suppresses TSH secretion from the pituitary, reduces conversion of T4 (the inactive storage hormone) to T3 (the active form used by cells), and upregulates reverse T3 (rT3), which blocks T3 receptors without activating them (NIH National Institute of Diabetes and Digestive and Kidney Diseases, thyroid hormone physiology overview). The net result is a functional hypothyroid state even when standard TSH labs look acceptable.

This is where ashwagandha's most robust clinical evidence becomes directly relevant. A double-blind, randomized, placebo-controlled trial by Chandrasekhar et al. published in the Indian Journal of Psychological Medicine (2012) enrolled 64 adults with a history of chronic stress. Participants taking 300 mg of KSM-66 ashwagandha root extract twice daily (600 mg/day total) for 60 days showed a 27.9% reduction in serum cortisol compared to placebo, alongside significant improvements on validated stress and anxiety scales (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).

A subsequent trial by Pratte et al. using the same KSM-66 extract at 300 mg twice daily replicated the cortisol-lowering effect with a similarly robust reduction in self-reported stress (Pratte et al., Journal of the International Society of Sports Nutrition 2014; PMID: 25364172). From a thyroid perspective, reducing the cortisol load on the HPT axis creates conditions where T4-to-T3 conversion can normalize and TSH can reflect actual thyroid reserve more accurately.

This cortisol-thyroid connection also explains why some individuals report improved energy, warmer hands and feet, and better morning alertness after several weeks on ashwagandha — symptoms consistent with improved peripheral T3 availability rather than any direct thyroid stimulation per se.

---

When to Take Ashwagandha for Thyroid and Hormonal Benefits

Timing is not arbitrary with ashwagandha. Because its most significant evidence relates to cortisol modulation, aligning intake with the cortisol rhythm makes physiological sense. Cortisol follows a diurnal pattern: it peaks sharply in the first 30–60 minutes after waking (the cortisol awakening response), remains elevated through mid-morning, and declines through the afternoon and evening.

For thyroid-related goals, the evidence and clinical practice suggest the following timing strategy:

1. Morning dose (with breakfast): Taking ashwagandha with food in the morning blunts the cortisol awakening response, setting a lower cortisol baseline for the day. This is especially relevant for people whose TSH or T3 labs fluctuate with stress loading.
2. Evening dose (with dinner): A second dose in the evening addresses the adaptogenic role during overnight recovery, when thyroid hormone synthesis and pituitary TSH pulsing are most active. Several clinical trials used a split 300 mg morning / 300 mg evening dosing schedule.
3. Avoid taking on an empty stomach: Ashwagandha's saponins can cause mild gastric irritation in sensitive individuals when taken fasted. Taking it with a fat-containing meal also improves absorption of its fat-soluble withanolides.

Consistency matters more than precision. Most trials showing thyroid and cortisol benefits ran for 8–12 weeks of daily use, suggesting that the adaptogenic effects are cumulative rather than acute.

---

Best Time to Take Ashwagandha: Morning, Evening, or Both?

The "best time to take ashwagandha" question generates enormous search traffic, and the honest answer depends on your primary goal. For thyroid and cortisol optimization specifically, the split-dose protocol (morning + evening) used in the Chandrasekhar 2012 trial is the most clinically supported approach. However, there are practical nuances:

If you are taking thyroid medication (levothyroxine/Synthroid), note that timing relative to medication matters. Levothyroxine is typically taken 30–60 minutes before eating, on an empty stomach. Taking ashwagandha at the same time would require food, creating a conflict. In this case, separate the two by at least 2 hours and consult your prescribing physician before adding any supplement to a thyroid medication regimen.

---

Ashwagandha vs L-Theanine: Which Is Better for Thyroid-Related Stress?

Both ashwagandha and L-theanine are frequently recommended for stress and anxiety, and both appear in thyroid-focused protocols — but they work through entirely different mechanisms and are not interchangeable.

Ashwagandha operates primarily through the HPA (hypothalamic-pituitary-adrenal) axis. It reduces cortisol synthesis, downregulates stress-pathway signaling (including hsp70 stress proteins and NF-kB), and over weeks of use shifts the body toward a lower-cortisol baseline. Its thyroid benefits are likely a downstream consequence of this HPA normalization.

L-theanine is a non-protein amino acid found in green tea that promotes alpha-wave brain activity and modulates GABA and glutamate neurotransmission. A randomized crossover trial by Kimura et al. found that 200 mg L-theanine reduced physiological and psychological stress responses to a cognitive stressor within 60 minutes of intake (Kimura et al., Biological Psychology 2007; PMID: 16930802). Its onset is acute rather than cumulative.

For thyroid-specific outcomes, ashwagandha has direct clinical evidence (the Sharma 2018 TSH/T3/T4 data). L-theanine has no published trials examining thyroid hormone levels. However, the two compounds are synergistic in stress management protocols: ashwagandha resets the chronic cortisol baseline over weeks, while L-theanine provides on-demand acute calm. Combining them is common in integrative thyroid protocols and is generally considered safe.

If you are evaluating adaptogens for the stress-thyroid connection, the clinical evidence for ashwagandha benefits and dosage resource and our rhodiola rosea vs ashwagandha comparison are useful companions to this article.

---

Important Cautions: When Ashwagandha May Not Be Right for Your Thyroid

Because ashwagandha appears to stimulate thyroid hormone production, individuals with hyperthyroidism (overactive thyroid) or Graves' disease should avoid it without direct physician supervision — adding thyroid stimulation to an already overactive system could worsen palpitations, anxiety, weight loss, or other hyperthyroid symptoms.

For Hashimoto's thyroiditis — the most common cause of hypothyroidism in the United States — the evidence is more nuanced. Ashwagandha has immunomodulatory properties that may theoretically influence the autoimmune response driving Hashimoto's, but no large randomized controlled trials have examined TPO antibody titers or thyroid ultrasound outcomes with ashwagandha supplementation. Individuals with Hashimoto's should treat the Sharma 2018 findings as preliminary and discuss supplementation with an endocrinologist or integrative medicine physician.

Additionally, rare cases of ashwagandha-associated liver injury have been reported in the literature (LiverTox, National Institutes of Health), particularly with very high doses or adulterated products. Sticking to standardized extracts like KSM-66 (tested for withanolide content and heavy metal contamination) and staying within the 300–600 mg/day clinical range minimizes this risk.

---

What This Means for Your Formula: How Ones Addresses Thyroid and Cortisol Support

A personalized approach to thyroid support goes beyond any single ingredient. Ones uses AI analysis of your blood work (including TSH, free T3, free T4, and cortisol where available), wearable data, and health history to build a custom capsule formula calibrated to your actual physiology — not a generic thyroid supplement stack.

For individuals whose data points toward thyroid underperformance driven by HPA axis dysregulation, Ones formulas commonly include:

• Ashwagandha KSM-66 at 600 mg/day — matching the dose used in the Sharma 2018 subclinical hypothyroidism RCT and the Chandrasekhar 2012 cortisol trial, split across the capsule plan for optimal diurnal coverage.
• Thyroid Support System Blend — Ones' proprietary Thyroid Support blend combines evidence-based micronutrients relevant to thyroid hormone synthesis and conversion, including selenomethionine (selenium is a cofactor for the deiodinase enzymes that convert T4 to active T3) and iodine at physiologically appropriate doses. These are dosed to clinical ranges, not token amounts.
• Magnesium Glycinate — Magnesium deficiency is prevalent in people with high cortisol loads and has been associated with impaired HPA axis regulation. Ones includes magnesium glycinate for sleep and cortisol support at 300–400 mg elemental magnesium, the range supported by NIH Office of Dietary Supplements guidance for adults.

Unlike broad-spectrum thyroid supplements sold at retail, Ones formulas adjust based on your specific lab markers — meaning if your free T3 is low-normal but your cortisol is elevated, your formula will prioritize cortisol normalization alongside thyroid cofactors rather than defaulting to a fixed thyroid stack. Formulas come in 6, 9, or 12-capsule plans, allowing for meaningful ingredient budgets without pill fatigue.

For those comparing personalized supplement platforms, it is worth noting that while Thorne and Ritual offer high-quality individual supplements and Function Health provides deep lab testing, none combine AI-driven lab interpretation with custom multi-ingredient capsule formulas the way Ones does — making it especially relevant for complex systems like thyroid health where several pathways need to be addressed simultaneously.

---

Key Takeaways

• Clinical evidence supports ashwagandha for subclinical hypothyroidism: A 2018 RCT (PMID: 29727607) found 600 mg/day KSM-66 significantly increased T3 and T4 while reducing TSH over 8 weeks in adults with subclinical hypothyroidism.
• Cortisol reduction is likely the primary mechanism: Ashwagandha lowers cortisol by up to 27.9% (PMID: 23439798), and chronic high cortisol suppresses T4-to-T3 conversion — making the HPA axis a critical target for thyroid optimization.
• Timing matters: A split morning/evening dose with food mirrors the protocols used in cortisol and thyroid RCTs; individuals on levothyroxine should separate dosing by at least 2 hours and consult their physician.
• Ashwagandha and L-theanine are complementary, not interchangeable: Ashwagandha resets the chronic cortisol baseline over weeks; L-theanine provides acute stress relief without direct thyroid hormone evidence.
• Hyperthyroidism and Graves' disease are contraindications: Ashwagandha's thyroid-stimulating properties make it potentially harmful in an overactive thyroid context without medical supervision.
• Personalized dosing beats one-size-fits-all: Ones matches KSM-66 ashwagandha to your actual TSH, cortisol, and thyroid panel data — pairing it with selenomethionine, magnesium glycinate, and Thyroid Support System Blend ingredients at clinically validated doses.